ATE135565T1 - Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten - Google Patents

Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten

Info

Publication number: ATE135565T1
Authority: AT; Austria
Prior art keywords: biologically active; polypeptides; peptides; active proteins; compositions containing
Prior art date: 1991-06-24

Application number

AT92107278T

Other languages

English (en)

Inventor

William David Steber

Susan Mancini Cady

David Farley Johnson

Main Street West

Theresa Rice

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-24

Filing date

1992-04-29

Publication date

1996-04-15

1992-04-29 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1996-04-15 Application granted granted Critical

1996-04-15 Publication of ATE135565T1 publication Critical patent/ATE135565T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/10—Stiffening bandages containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Zoology (AREA)
Materials Engineering (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Prostheses (AREA)

AT92107278T 1991-06-24 1992-04-29 Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten ATE135565T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US71989891A	1991-06-24	1991-06-24

Publications (1)

Publication Number	Publication Date
ATE135565T1 true ATE135565T1 (de)	1996-04-15

Family

ID=24891827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92107278T ATE135565T1 (de)	1991-06-24	1992-04-29	Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten

Country Status (24)

Country	Link
EP (1)	EP0523330B1 (de)
JP (1)	JP3597205B2 (de)
KR (1)	KR100221031B1 (de)
CN (1)	CN1050301C (de)
AT (1)	ATE135565T1 (de)
AU (1)	AU656200B2 (de)
BR (1)	BR9202374A (de)
CA (1)	CA2071757C (de)
DE (1)	DE69209173T2 (de)
DK (1)	DK0523330T3 (de)
ES (1)	ES2087337T3 (de)
GE (1)	GEP19970992B (de)
GR (1)	GR3019457T3 (de)
HU (1)	HU217547B (de)
IE (1)	IE74398B1 (de)
IL (1)	IL102287A (de)
LV (1)	LV11816B (de)
MD (1)	MD1394G2 (de)
MX (1)	MX9203175A (de)
RU (1)	RU2080119C1 (de)
SG (1)	SG47955A1 (de)
TW (1)	TW215058B (de)
UA (1)	UA26137C2 (de)
ZA (1)	ZA924613B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736152A (en) *	1995-10-27	1998-04-07	Atrix Laboratories, Inc.	Non-polymeric sustained release delivery system
BR9912275A (pt)	1998-07-20	2001-04-17	Peptech Ltd	Formulação de bioimplante
US8052982B2 (en)	1998-07-20	2011-11-08	Peptech Animal Health Pty Limited	Bioimplant formulation comprising lecithin and stearin
JP2001058955A (ja) *	1999-06-17	2001-03-06	Inst Of Physical & Chemical Res	生理活性ペプチド徐放性製剤
KR20090007504A (ko)	2000-02-24	2009-01-16	몬산토 테크놀로지 엘엘씨	소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
KR20030023878A (ko)	2000-06-26	2003-03-20	몬산토 테크놀로지 엘엘씨	소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들
US6664234B1 (en)	2000-06-30	2003-12-16	Monsanto Technology Llc	Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) *	2000-10-02	2012-05-16	日本ケミカルリサーチ株式会社	生理活性ペプチド含有粉末
DE10161078A1 (de) *	2001-12-12	2003-08-28	Achim Goepferich	Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
JP2005145821A (ja) *	2003-11-11	2005-06-09	Kao Corp	打錠製剤
EA201290542A1 (ru)	2009-12-21	2013-07-30	Амбркс, Инк.	Модифицированные свиные соматотропиновые полипептиды и их применение
JP2013515080A (ja)	2009-12-21	2013-05-02	アンブルックス，インコーポレイテッド	修飾されているウシのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4271113A (en) *	1978-04-17	1981-06-02	Alza Corporation	Process for forming a passageway in an osmotic device
CA1257199A (en) *	1986-05-20	1989-07-11	Paul Y. Wang	Preparation containing bioactive macromolecular substance for multi-months release in vivo
US4863736A (en) *	1987-03-16	1989-09-05	Monsanto Company	Somatotropin prolonged release
US4795644A (en) *	1987-08-03	1989-01-03	Merck & Co., Inc.	Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
CA2088982A1 (en) *	1990-08-09	1992-02-10	Robert J. Leonard	Multiple drug delivery system

1992
- 1992-04-29 SG SG1996005631A patent/SG47955A1/en unknown
- 1992-04-29 DK DK92107278.1T patent/DK0523330T3/da active
- 1992-04-29 ES ES92107278T patent/ES2087337T3/es not_active Expired - Lifetime
- 1992-04-29 EP EP92107278A patent/EP0523330B1/de not_active Expired - Lifetime
- 1992-04-29 AT AT92107278T patent/ATE135565T1/de not_active IP Right Cessation
- 1992-04-29 DE DE69209173T patent/DE69209173T2/de not_active Expired - Fee Related
- 1992-05-04 TW TW081103470A patent/TW215058B/zh active
- 1992-06-19 JP JP18465792A patent/JP3597205B2/ja not_active Expired - Fee Related
- 1992-06-22 CA CA002071757A patent/CA2071757C/en not_active Expired - Fee Related
- 1992-06-22 IL IL10228792A patent/IL102287A/xx not_active IP Right Cessation
- 1992-06-23 ZA ZA924613A patent/ZA924613B/xx unknown
- 1992-06-23 HU HU9202092A patent/HU217547B/hu not_active IP Right Cessation
- 1992-06-23 KR KR1019920010911A patent/KR100221031B1/ko not_active IP Right Cessation
- 1992-06-23 AU AU18470/92A patent/AU656200B2/en not_active Ceased
- 1992-06-23 BR BR929202374A patent/BR9202374A/pt not_active Application Discontinuation
- 1992-06-23 CN CN92105065A patent/CN1050301C/zh not_active Expired - Fee Related
- 1992-06-23 RU SU925052163A patent/RU2080119C1/ru not_active IP Right Cessation
- 1992-06-23 MX MX9203175A patent/MX9203175A/es not_active IP Right Cessation
- 1992-07-01 IE IE922020A patent/IE74398B1/en not_active IP Right Cessation
1993
- 1993-06-15 UA UA93002879A patent/UA26137C2/uk unknown
- 1993-07-31 GE GEAP19931351A patent/GEP19970992B/en unknown
1994
- 1994-07-12 MD MD94-0370A patent/MD1394G2/ro unknown
1996
- 1996-03-29 GR GR950403216T patent/GR3019457T3/el unknown
1997
- 1997-03-05 LV LVP-97-37A patent/LV11816B/xx unknown

Also Published As

Publication number	Publication date
AU1847092A (en)	1993-01-07
JPH05186363A (ja)	1993-07-27
LV11816B (en)	1997-12-20
MD1394F2 (en)	2000-01-31
HU217547B (hu)	2000-02-28
MD940370A (en)	1996-06-28
HU9202092D0 (en)	1992-09-28
IE74398B1 (en)	1997-07-30
ES2087337T3 (es)	1996-07-16
CA2071757A1 (en)	1992-12-25
AU656200B2 (en)	1995-01-27
ZA924613B (en)	1993-03-31
MD1394G2 (ro)	2000-11-30
IL102287A0 (en)	1993-01-14
BR9202374A (pt)	1993-01-26
LV11816A (lv)	1997-08-20
RU2080119C1 (ru)	1997-05-27
DK0523330T3 (da)	1996-04-15
CN1068965A (zh)	1993-02-17
HUT61486A (en)	1993-01-28
IE922020A1 (en)	1992-12-30
JP3597205B2 (ja)	2004-12-02
MX9203175A (es)	1993-04-01
TW215058B (de)	1993-10-21
EP0523330B1 (de)	1996-03-20
UA26137C2 (uk)	1999-06-07
DE69209173D1 (de)	1996-04-25
KR930000131A (ko)	1993-01-15
CA2071757C (en)	2003-06-10
CN1050301C (zh)	2000-03-15
GR3019457T3 (en)	1996-06-30
KR100221031B1 (ko)	1999-09-15
SG47955A1 (en)	1998-04-17
DE69209173T2 (de)	1996-11-28
GEP19970992B (en)	1997-11-20
EP0523330A1 (de)	1993-01-20
IL102287A (en)	2000-06-01

Publication	Publication Date	Title
NZ227788A (en)	1991-10-25	Peptide having growth hormone regulatory effects, and compositions
FI954978A0 (fi)	1995-10-18	Modifioidut proteiini- ja peptidilääkeaineet
EP0526544A4 (en)	1993-08-11	Therapeutic uses of actin-binding compounds
ATE135565T1 (de)	1996-04-15	Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten
DE3585556D1 (de)	1992-04-16	Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
ES2031806T3 (es)	1997-01-01	Factor de permeabilidad vascular humano.
EP0212474A3 (de)	1988-11-17	Morphogenetische Knochenpeptide
PT97316A (pt)	1991-12-31	Sequencias de dna,construcoes de dna e metodo para a sua aplicacao no tratamento de doencas celulares proliferativas
ATE142693T1 (de)	1996-09-15	Herstellung des vaskulären endothelialen zellwachstumsfaktors
KR910007542A (ko)	1991-05-30	폴리펩타이드의 서방형 조성물
DK336986A (da)	1987-01-16	Fremgangsmaade til fremstilling af taerre biologisk aktive rekombinante vaeksthormoner
GR3031927T3 (en)	2000-03-31	Cysteine depleted il-6 muteins
FI885851A0 (fi)	1988-12-16	Biologiskt resorberbart implantationsmaterial samt foerfarande foer framstaellning daerav.
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE59611330D1 (de)	2006-04-20	Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
KR920700224A (ko)	1992-02-19	신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
CO4230067A1 (es)	1995-10-19	Composicion cosmetica para el cuidado de la piel
MX9604539A (es)	1997-09-30	Aminoacidos modificados para la distribucion de farmaco.
BG60657B2 (en)	1995-11-30	Human recombinant interleukin-2 muteins
IL97372A0 (en)	1992-05-25	Method for the quantitative determination of the biologically active form of the human nerve growth factor in protein liquids

Legal Events

Date	Code	Title	Description
1996-10-15	UEP	Publication of translation of european patent specification
2005-01-15	REN	Ceased due to non-payment of the annual fee